Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-09, Stock:NVS, The news for the past five days is as follows:
2019-10-02: NEWS1: Novartis (NVS) Announces Data on Asthma Drugs & Kisqali.NEWS2: The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data.NEWS3: Bausch shares slide on suit against Novartis unit Sandoz over blockbuster drug patents.
2019-10-03: NEWS1: Bausch Files Lawsuit Against Novartis' Sandoz, Shares Down.NEWS2: Novartis Reports Additional Data on Spondylitis Drug Cosentyx.
2019-10-04: NEWS1: A Key Novartis Drug Could Be Delayed — Why This Stock Is Cheering.NEWS2: Why This Biotech Stock Is Cheering A Potential Novartis Biosimilar Delay.NEWS3: Puma Biotech Gets FDA Nod of Labeling Supplement for Nerlynx.NEWS4: Pharma Stock Roundup: JNJ's Opioid Settlement, FDA Updates for AZN, GSK, MRK, RHHBY.NEWS5: Here is Hedge Funds’ 30th Most Popular Stock Pick.
2019-10-07: NEWS1: Is Novartis AG  (NVS) A Good Stock To Buy According To Hedge Funds?.NEWS2: AstraZeneca's Fasenra Gets FDA Nod for Self-Administration.
2019-10-08: NEWS1: Can This Pharma Giant Undercut Regeneron's Biggest Moneymaker?.NEWS2: How Novartis Is Aiming To Undercut Regeneron's Biggest Moneymaker.NEWS3: Is Novartis (NVS) Outperforming Other Medical Stocks This Year?.NEWS4: Biogen Strengthens MS & SMA Portfolio as Competition Lurks.NEWS5: CORRECTED-UPDATE 2-Novartis gets FDA boost in crowded eye drug market.

Answer: Rise